Device Trial Radar · NCT04573959
Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System
Last checked: Nov 20, 2026Latest source record: Oct 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
84
Actual
Start
Oct 1, 2015
Primary completion
Jun 11, 2020
Study completion Jun 11, 2020
Sponsor
- Lead sponsor
- Capso Vision, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Generic Devices Consulting, Inc.
- First posted
- Oct 5, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To validate an updated version of CapsoCam® SV-3 Endoscopy System brand name CapsoCam Plus™) with respect to the reproducibility of the system to capture and download small bowel images in a manner consistent with the predicate CapsoCam® SV-2 and SV-3 capsule endoscopy systems.
Conditions
- Intestinal Disease
- Inflammatory Bowel Diseases
- Crohn Disease
- Ulcer
- Celiac Disease
Interventions
SV-3 Capsule EndoscopyDevice
The purpose of this study is to validate an updated version of the CapsoCam SV-3 Endoscopy System with respect to the reproducibility of the system to capture and download small bowel images in a manner consistent with the predicate CapsoCam SV-3 capsule endoscopy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ability to capture imagesTime frame: 2 weeks
- Ability to download imagesTime frame: 2 weeks
- Diagnostic Quality of ImagesTime frame: 2 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CapsoVision, Inc.
Saratoga, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.